Amwell’s R&D costs skyrocket amid infrastructure bet with Converge platform
The vendor’s revenue grew 11% while expenses climbed 40% year over year, as Amwell invested heavily in research and development for its open architecture Converge platform.
The vendor’s revenue grew 11% while expenses climbed 40% year over year, as Amwell invested heavily in research and development for its open architecture Converge platform.